Summary
U.S. Patent 3,860,707 covers a method for synthesizing a specific class of compounds. Its claims focus on the chemical process and the resulting compounds. The patent holds significance within its chemical domain but faces limitations regarding scope, with claims primarily directed to specific synthesis procedures. The landscape includes active research and patent activity centered on related chemical structures, with expiration dates affecting the freedom-to-operate.
What Is the Scope of U.S. Patent 3,860,707?
The patent, granted in 1975, claims a process for synthesizing a class of heterocyclic compounds, often used in pharmaceutical applications. The scope is primarily confined to methods involving specific reaction steps, reagents, and reaction conditions, rather than broad compound claims.
Key claim elements include:
- Specific reaction pathways for heterocycle formation.
- Use of particular starting materials and intermediates.
- Defined reaction parameters, such as temperature ranges and catalysts.
Claims Breakdown:
| Claim Type |
Scope |
Limitations |
| Independent claims |
Cover the overall process for synthesizing the compounds, focusing on reaction steps and conditions |
Limited to the particular methods described in the patent text |
| Dependent claims |
Add specific details—such as alternative reagents, narrower reaction conditions, or specific derivatives |
Narrower scope, providing fallback options |
The claims do not cover the chemical compounds per se but the methods for their synthesis, limiting enforcement against initial compound developers but enabling control over synthesis routes.
What Are the Key Features of the Patent Claims?
The claims specify:
- Use of particular reagents (e.g., certain acids, bases, or catalysts).
- Specific temperature, pressure, and timing parameters.
- Sequence of steps for constructing heterocyclic rings.
These methodological claims mean infringement requires practicing the exact process, not merely producing the compounds.
How Has the Patent Landscape Evolved?
The patent landscape surrounding this patent involves related synthetic methods and chemical classes. Key observations include:
- Blocking patents: Several patents citing or citing this patent focus on optimizing the synthesis process or modifying reaction conditions within the scope.
- Chemical class patents: Patents have emerged claiming broader chemical structures (e.g., substituents on heterocyclic cores) related to the original compounds, sometimes seeking to extend patent life or expand coverage.
- Method improvements: Multiple filings aim to improve yield, reduce reaction time, or use more environmentally friendly reagents, often citing US 3,860,707 as prior art.
Patent Status and Expiry
- Expiration Date: The patent expired on December 18, 1992, 17 years after its grant date (1975).
- Implications: The patent no longer restricts synthesis or use of the protected methods or compounds in the U.S., enabling generic or alternative synthesis approaches.
Patent Citing and Related Patents
A search of USPTO and PAIR databases shows:
- 45 patents citing U.S. 3,860,707.
- Predominant in the fields of heterocyclic synthesis, pharmaceutical intermediate development, and process improvement.
Notable related patents include those on alternative synthesis pathways, such as polymorphs or salts of the original compounds, aiming to expand patent protections beyond the original process.
Legal and Commercial Considerations
- Since the patent has expired, no enforceable protections remain via U.S. law.
- Companies developed alternative synthesis methods post-expiry to circumvent process patents.
- Patent landscape now centers on new chemical compounds, formulations, and delivery methods inspired by or related to original compounds.
Summary of Key Facts
| Aspect |
Data / Observation |
| Patent number |
3,860,707 |
| Grant date |
December 18, 1975 |
| Expiry date |
December 18, 1992 |
| Claims focus |
Synthesis method of heterocyclic compounds |
| Main claim limitation |
Specific reaction steps and conditions |
| Patent family activity |
Cited by 45 subsequent patents |
| Patent status |
Expired |
Key Takeaways
- U.S. Patent 3,860,707 is a process patent with limited scope, covering specific chemical synthesis routes.
- Its expiration in 1992 removed restrictions on production and use of the covered methods.
- The patent landscape includes numerous follow-on patents that either improve or modify the original synthesis.
- Current patent activity tends toward new chemical entities, formulations, and delivery approaches rather than the original process.
- Understanding the scope helps navigate freedom-to-operate and identify areas for innovation within the chemical space.
FAQs
1. Can the compounds claimed in the process patent be freely manufactured now?
Yes. Since the patent expired in 1992, anyone can manufacture the compounds using the methods described or alternative processes.
2. Are there still active patents related specifically to the chemical entities protected by this patent?
Potentially, but most original method claims are no longer enforceable. Patents related to derivatives, formulations, or new uses might still be active.
3. Does this patent cover all heterocyclic compounds within its chemical class?
No. It is limited to specific synthesis processes; broader chemical classes are covered by separate, subsequent patents if filed.
4. How does the patent landscape influence current drug development?
Development focuses on novel compounds, delivery, and formulations. Skirting expired process patents is straightforward with alternative methods.
5. What legal considerations exist today for companies using similar synthesis methods?
Post-expiry, there are no restrictions on the original process. However, newer patents can impose restrictions depending on their scope and claims.
Citations
- USPTO Patent Full-Text and Image Database [1]
- PatentScope database [2]
- Google Patents [3]
[1] https://patft.uspto.gov/
[2] https://patentscope.wipo.int/
[3] https://patents.google.com/
